 | Up a level |
2017
Gorska, A., Gruchala-Niedoszytko, M., Niedoszytko, M., Rabenhorst, A., Sperr, W., Elberink, Oude J., Lange, M., Gleixner, K., Brazzelli, V, Fontana, E., Vos, B., Reiter, A., Schwaab, J., Zanotti, R., Bonadonna, P., Triggiani, M., Gotlib, J., Doubek, M., Jakob, T., Fuchs, D., Sabato, V, Zink, A., Bretterklieber, A., Jaekel, N., Sotlar, K., Horny, H., Fortina, Belloni A., Merante, S., Kluin-Nelemans, H., Valent, P. and Hartmann, K. (2017). The body mass index is an indicator of advanced systemic mastocytosis: preliminary results from a registry project of the European Competence Network on Mastocytosis (ECNM) registry. Allergy, 72. S. 126 - 128. HOBOKEN: WILEY. ISSN 1398-9995
Jawhar, M., Naumann, N., Knut, M., Schneider, B., Ghazzawi, M., Kreuzer, K-A., Hallek, M., Fabarius, A., Score, J., Chase, A., Tapper, W., Reiter, A. and Cross, N. (2017). ZMYM2-FLT3 IS A RARE, RECURRENT, CYTOGENTICALLY CRYPTIC FUSION IN MYELOID/LYMPHOID NEOPLASMS WITH EOSINOPHILIA THAT IS RESPONSIVE TO FLT3 INHIBITION. Haematologica, 102. S. 553 - 554. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Jawhar, M., Naumann, N., Knut, M., Score, J., Ghazzawi, M., Schneider, B., Kreuzer, K-A, Hallek, M., Drexler, H. G., Chacko, J., Wallis, L., Fabarius, A., Metzgeroth, G., Hofmann, W-K, Chase, A., Tapper, W., Reiter, A. and Cross, N. C. P. (2017). Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia. Leukemia, 31 (10). S. 2271 - 2275. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Jawhar, M., Naumann, N., Knut, M., Score, J., Ghazzawi, M., Schneider, B., Kreuzer, K. -A., Hallek, M., Chacko, J., Wallis, L., Schwaab, J., Metzgeroth, G., Hofmann, W. -K., Fabarius, A., Chase, A., Tapper, W., Cross, N. C. P. and Reiter, A. (2017). Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasm with eosinophilia. Oncol. Res. Treat., 40. S. 150 - 151. BASEL: KARGER. ISSN 2296-5262
Niedoszytko, M., Gorska, A., Nedoszytko, B., Rabenhorst, A., Sperr, W., Elberink, Oude J., Lange, M., Gleixner, K., Brazzelli, V, Fontana, E., Vos, B., Reiter, A., Schwaab, J., Zanotti, R., Bonadonna, P., Triggiani, M., Gotlib, J., Doubek, M., Jakob, T., Fuchs, D., Sabato, V, Zink, A., Bretterklieber, A., Jaekel, N., Sotlar, K., Horny, H., Fortina, Belloni A., Merante, S., Kluin-Nelemans, H., Valent, P. and Hartmann, K. (2017). Impact of allergic disorders and anaphylaxis in mastocytosis: Preliminary data from a study of the European Competence Network on Mastocytosis (ECNM) registry. Allergy, 72. S. 212 - 214. HOBOKEN: WILEY. ISSN 1398-9995
Rabenhorst, A., Annecke, T., Drinhaus, H., Schroeder, D., Gehring, M., Leja, S., Schwaab, J., Reiter, A., Raap, U. and Hartmann, K. (2017). Glycocalyx shedding in mastocytosis correlates with disease severity. Exp. Dermatol., 26 (3). S. E8 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Rabenhorst, A., Sperr, W., Elberink, J. Oude, Lange, M., Gleixner, K., Brazzelli, V., Fontana, E., Vos, B., Gorska, A., Reiter, A., Schwaab, J., Zanotti, R., Bonadonna, P., Triggiani, M., Gotlib, J., Doubek, M., Jakob, T., Kilbertus, A., Sabato, V., Zink, A., Bretterklieber, A., Jaekel, N., Sotlar, K., Horny, H., Fortina, A. Belloni, Merante, S., Niedoszytko, M., Kluin-Nelemans, H., Valent, P. and Hartmann, K. (2017). Age at disease onset has a major impact on clinical characteristics and course of mastocytosis. Exp. Dermatol., 26 (3). S. E6 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Reiter, A., Kluin-Nelemans, H. C., George, T., Akin, C., DeAngelo, D. J., Hermine, O., Awan, F., Hexner, E., Mauro, M., Schwaab, J., Jawhar, M., Sternberg, D., Berkowitz, N., Niolat, J., Labed, A. Huntsman, Hartmann, K., Horny, H-P., Valent, P. and Gotlib, J. (2017). POOLED SURVIVAL ANALYSIS OF MIDOSTAURIN CLINICAL STUDY DATA (D2201+A2213) IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS COMPARED WITH HISTORICAL CONTROLS. Haematologica, 102. S. 321 - 323. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Stegelmann, F., Griesshammer, M., Koschmieder, S., Reiter, A., Hochhaus, A., Heidel, F., von, Bubnoff N., Kindler, T., Hebart, H., Bangerter, M., Wolleschak, D., Moehle, R., Scheid, C., Reim, R., Sutter, U., Vetter, K., Doehner, H. and Doehner, K. (2017). Pomalidomide plus ruxolitinib in myelofibrosis: Updated results from the MPNSG-0212 trial. Oncol. Res. Treat., 40. S. 149 - 150. BASEL: KARGER. ISSN 2296-5262
Stegelmann, F., Griesshammer, M., Koschmieder, S., Reiter, A., Hochhaus, A., Heidel, F., von Bubnoff, N., Kindler, T., Hebart, H., Bangerter, M., Wolleschak, D., Moehle, R., Scheid, C., Reim, R., Sutter, U., Vetter, K., Doehner, H. and Doehner, K. (2017). COMBINATION THERAPY OF POMALIDOMIDE PLUS RUXOLITINIB IN MYELOFIBROSIS: RESULTS FROM COHORT 1 OF THE MPNSG-0212 TRIAL (NCT01644110). Haematologica, 102. S. 280 - 281. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
2016
Gratwohl, A., Pfirrmann, M., Zander, A., Kroger, N., Beelen, D., Novotny, J., Nerl, C., Scheid, C., Spiekermann, K., Mayer, J., Sayer, H. G., Falge, C., Bunjes, D., Doehner, H., Ganser, A., Schmidt-Wolf, I., Schwerdtfeger, R., Baurmann, H., Kuse, R., Schmitz, N., Wehmeier, A., Fischer, J. Th, Ho, A. D., Wilhelm, M., Goebeler, M-E, Lindemann, H. W., Bormann, M., Hertenstein, B., Schlimok, G., Baerlocher, G. M., Aul, C., Pfreundschuh, M., Fabian, M., Staib, P., Edinger, M., Schatz, M., Fauser, A., Arnold, R., Kindler, T., Wulf, G., Rosselet, A., Hellmann, A., Schaefer, E., Pruemmer, O., Schenk, M., Hasford, J., Heimpel, H., Hossfeld, D. K., Kolb, H-J, Buesche, G., Haferlach, C., Schnittger, S., Mueller, M. C., Reiter, A., Berger, U., Saussele, S., Hochhaus, A. and Hehlmann, R. (2016). Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia, 30 (3). S. 562 - 570. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Jawharl, M., Naumann, N., Schwaab, J., Dietz, C., Casper, J., Dang, T. A., Dietze, L., Doehner, K., Haenel, A., Lathan, B., Link, H., Lotfti, S., Mielkel, S., Luber, V., Maywald, O., Mueller, L., Platzbecker, U., Pruemmer, O., Thomssen, H., Toepelt, K., Schmitt, K., Baurmann, H., Vielert, T., Hofmann, W. K., Haferlach, C., Cross, N. C., Fabarius, A., Reiter, A. and Metzgeroth, G. (2016). CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME ON IMATINIB IN PATIENTS WITH MYELOID/LYMPHOID NEOPLASMS AND ASSOCIATED PDGFRB FUSION GENES IN CHRONIC OR BLAST PHASE. Haematologica, 101. S. 264 - 266. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Rabenhorst, A., Leja, S., Schwaab, J., Gehring, M., Foerster, A., Reiter, A., Raap, U. and Hartmann, K. (2016). Serum levels of programmed cell death ligand-1 are increased in mastocytosis and correlate with disease severity. Exp. Dermatol., 25 (3). S. E1 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Stegelmann, F., Hebart, H., Bangerter, M., Wolleschak, D., Griesshammer, M., Koschmieder, S., Hochhaus, A., Heidel, F., Moehle, R., Reiter, A., Scheid, C., von Bubnoff, N., Kirschbaum, R., Reim, R., Sutter, U., Vetter, K., Doehner, H., Schlenk, R. F. and Doehner, K. (2016). Ruxolitinib/Pomalidomide combination therapy in myelofibrosis: Current data from the MPNSG-0212 trial. Oncol. Res. Treat., 39. S. 233 - 235. BASEL: KARGER. ISSN 2296-5262
2015
Stegelmann, F., Bangerter, M., Griesshammer, M., Hebart, H., Heidel, F., Hochhaus, A., Moehle, R., Reiter, A., Scheid, C., Kirschbaum, R., Reim, R., Sutter, U., Doehner, H., Schlenk, R. F. and Doehner, K. (2015). A phase-Ib/II study of ruxolitinib plus pomalidomide in Myelofibrosis: Data from the MPNSG-0212 Trial (NCT01644110). Oncol. Res. Treat., 38. S. 216 - 218. BASEL: KARGER. ISSN 2296-5262
2014
Valent, P., Escribano, L., Broesby-Olsen, S., Hartmann, K., Grattan, C., Brockow, K., Niedoszytko, M., Nedoszytko, B., Elberink, J. N. G. Oude, Kristensen, T., Butterfield, J. H., Triggiani, M., Alvarez-Twose, I., Reiter, A., Sperr, W. R., Sotlar, K., Yavuz, S., Kluin-Nelemans, H. C., Hermine, O., Radia, D., van Doormaal, J. J., Gotlib, J., Orfao, A., Siebenhaar, F., Schwartz, L. B., Castells, M., Maurer, M., Horny, H. -P., Akin, C., Metcalfe, D. D. and Arock, M. (2014). Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis. Allergy, 69 (10). S. 1267 - 1275. HOBOKEN: WILEY. ISSN 1398-9995
Valent, P., Sotlar, K., Sperr, W. R., Escribano, L., Yavuz, S., Reiter, A., George, T. I., Kluin-Nelemans, H. C., Hermine, O., Butterfield, J. H., Hagglund, H., Ustun, C., Hornick, J. L., Triggiani, M., Radia, D., Akin, C., Hartmann, K., Gotlib, J., Schwartz, L. B., Verstovsek, S., Orfao, A., Metcalfe, D. D., Arock, M. and Horny, H. -P. (2014). Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal. Ann. Oncol., 25 (9). S. 1691 - 1701. AMSTERDAM: ELSEVIER. ISSN 1569-8041